San Franciscan biotech startup, Cambrian Genomics, has continued their pursuit to make DNA an affordable consumer product with their DNA laser 3D printing technology (outlined in the video below). A recent acquisition of $10 million in private funding has not pushed CEO Austen Heinz to back off from his 
Cambrian Genomics CEO Austen Heinz
Being able to mass-produce DNA allows medical scientists and researchers to push into unexplored territories only dreamed of by science fiction writers. While Heinz said that his technology could indeed be used to alter the DNA of our offspring to fit our liking, it could also lead to advances that could eradicate genetic disorders like cystic fibrosis and birth defects.
Realistically, we’re not going to be able to cure genetic disorders without granting humanity the ability to alter its own genome in other, less medically necessary ways. Much like cosmetic surgery, there is money in the customization of the human body, and anyone who thinks that the idea of tailoring your perfect child before conception won’t be enticing to a lot of people are fooling themselves. It’s also important to remember that quite a few medical advances and surgery techniques that have saved countless lives weren’t developed in research labs but rather the operating rooms of cosmetic surgeons.
